Back to Results
First PageMeta Content
Protease inhibitors / Medicinal chemistry / Pyridines / Food and Drug Administration / United States Department of Health and Human Services / Tipranavir / Boehringer Ingelheim / Pharmaceutical drug / Center for Drug Evaluation and Research / Pharmacology / Pharmaceutical sciences / Clinical research


Food and Drug Administration Center for Drug Evaluation and Research (CDER) Antiviral Drugs Advisory Committee May 19, 2005
Add to Reading List

Document Date: 2005-05-25 15:51:21


Open Document

File Size: 29,50 KB

Share Result on Facebook

Company

M.D. / Boehringer Ingelheim Pharmaceuticals Inc. / Sponsor Presentations Boehringer Ingelheim Pharmaceuticals Inc. / M.P.H. / /

Facility

Women’s Hospital / /

MedicalCondition

HIV / AIDS / /

Organization

Food and Drug Administration Center for Drug Evaluation and Research / Harvard / Antiviral Drugs Advisory Committee / FDA / FDA Presentations Division of Antiviral Drug Products Efficacy Evaluation Rafia Bhore / Division of AIDS / Women’s Hospital / /

Person

Burkhard Blank / Pharmacometrics Reviewer / Christopher Corsico / Rafia Bhore / Scott McCallister / Jenny J. Zheng / Yuanchao (Derek) Zhang / Janet Englund / Statistical Reviewer / Debra B. Birnkrant / Anuja Patel / Tipranavir Daniel Kuritzkes / Lisa Naeger / Drug Surveillance / Andrea James / /

Position

Senior Vice President / Executive Secretary / Senior Vice President Medicine/DRA Tipranavir Development Douglas Mayers / International Head / Global Medical Team Leader / Chair / Director / Division of Antiviral Drug Products / Current Clinical Practice Director of AIDS Research / Associate Professor of Medicine / M.D. Head / /

Product

Aptivus / /

ProvinceOrState

Maryland / /

SocialTag